Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017
Muhammad Furqan(University of Iowa), Lawrence Feldman(University of Illinois Chicago), Kathleen Kennedy(Illinois College), Mary Pasquinelli(University of Illinois Chicago), Li Liu(University of Illinois Urbana-Champaign), Ardaman Shergill(University of Chicago), Sarah L. Mott(University of Iowa), Alicia Hulbert(Johns Hopkins University), Jyoti Malhotra(City Of Hope National Medical Center)
Cited by 3
Related Papers
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
|The Lancet|2023|319
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
|Clinical Cancer Research|2016|293
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274